NEW YORK (GenomeWeb) – Abbott today said that its Diagnostics business grew sales 43 percent year over year.

For the three months ended Sept. 30, 2018 the Abbott Park, Illinois-based firm reported overall revenues of $7.66 billion, up 12 percent on a reported basis from $6.83 billion a year ago. Organically, revenues grew 8 percent. The company beat the consensus Wall Street estimate of $7.65 billion.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.